GeoVax Labs, Inc. (GOVX) vs Moleculin Biotech, Inc. (MBRX)
A side-by-side comparison of GeoVax Labs, Inc. and Moleculin Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOVX
GeoVax Labs, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 2:27 PM EDT
MBRX
Moleculin Biotech, Inc.
$0.44HealthcareDelayed quote: Oct 6, 2026, 2:23 PM EDT
Total return — GOVX vs MBRX
growth of $100 · dividends reinvested · last 4yGOVX -100.0% (-94.2%/yr)MBRX -87.7% (-40.8%/yr)MBRX compounded faster over this window
Log scale — wide-divergence pair
GOVX MBRX
GOVX vs MBRX: by the numbers
- •MBRX is the larger company ($2M vs $2M market cap).
- •Both run net losses; MBRX's is the smaller (0.00% vs -862.34% net margin).
Metrics side by side
Valuation
| Metric | GOVX | MBRX |
|---|---|---|
| P/B ratio | 1.23 | 0.20 |
Profitability
| Metric | GOVX | MBRX |
|---|---|---|
| Gross margin | -628.02% | 0.00% |
| Operating margin | -869.34% | 0.00% |
| Net margin | -862.34% | 0.00% |
| ROE | -1160.10% | -261.73% |
| ROIC | -985.20% | -242.25% |
Growth (annualized)
| Metric | GOVX | MBRX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -78.48% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.